Chinese Thoracic Society. Expert consensus on the diagnosis, treatment and management of mild bronchial asthma in China (2023 edition). Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(9):880–96.

Google Scholar 

Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.

Article  Google Scholar 

Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org. Accessed 16 May 2024.

Dusser D, Montani D, Chanez P, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591–604.

Article  CAS  PubMed  Google Scholar 

FitzGerald JM, Barnes PJ, Chipps BE, et al. The burden of exacerbations in mild asthma: a systematic review. ERJ Open Res. 2020;6(3):00359–2019.

Article  PubMed  PubMed Central  Google Scholar 

Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–18.

Article  PubMed  Google Scholar 

Shang B, Li X, Xu Y, et al. Clinical characteristics and economic burden of asthma in china: a multicenter retrospective study. Iran J Allergy Asthma Immunol. 2023;22(3):290–8.

PubMed  Google Scholar 

Garcia G, van Dijkman SC, Pavord I, et al. A simulation study of the effect of clinical characteristics and treatment choice on reliever medication use, symptom control and exacerbation risk in moderate-severe asthma. Adv Ther. 2024;41(8):3196–216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daley-Yates P, Singh D, Igea JM, et al. Assessing the effects of changing patterns of inhaled corticosteroid dosing and adherence with fluticasone furoate and budesonide on asthma management. Adv Ther. 2023;40(9):4042–59.

Article  PubMed  PubMed Central  Google Scholar 

Scichilone N. Asthma control: the right inhaler for the right patient. Adv Ther. 2015;32(4):285–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment. Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023). Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(11):1055–67.

Google Scholar 

Park HS, Yoon D, Lee HY, et al. Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metered-dose inhalers in patients with asthma treated with ICS/LABA. Respirology. 2019;24(7):972–9.

Article  PubMed  Google Scholar 

Aggarwal AN, Kumari R, Grover S. Patient satisfaction with inhaled medication for asthma. Respir Care. 2018;63(7):859–64.

Article  PubMed  Google Scholar 

Srichana T, Juthong S, Thawithong E, Supaiboonpipat S, Soorapan S. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler. Clin Respir J. 2016;10(1):74–82.

Article  CAS  PubMed  Google Scholar 

Muraki M, Gose K, Hanada S, Sawaguchi H, Tohda Y. Which inhaled corticosteroid and long-acting beta-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler? Drug Deliv. 2017;24(1):1395–400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dusser D, Vicaut E, Lefrançois G. Formoterol HFA group. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Respiration. 2005;72(Suppl 1):20–7.

Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. J Allergy Clin Immunol. 2008;121(6):1407-1414.e14146.

Article  CAS  PubMed  Google Scholar 

Al-Ahmad M, Webb D. A prospective study of switching asthma patients from a fixed-dose combination (FDC) inhaled corticosteroid [ICS]/long-acting beta agonist [LABA] therapy delivered by dry powder inhaler (DPI) to ICS/LABA delivered by pressurised metered dose inhaler (pMDI). Respir Med. 2022;194:106771.

Article  PubMed  Google Scholar 

Cataldo D, Hanon S, Peché RV, et al. How to choose the right inhaler using a patient-centric approach. Adv Ther. 2022;39(3):1149–63.

Article  PubMed  PubMed Central  Google Scholar 

Haughney J, Lee AJ, McKnight E, Pertsovskaya I, O’Driscoll M, Usmani OS. Peak inspiratory flow measured at different inhaler resistances in patients with asthma. J Allergy Clin Immunol Pract. 2021;9(2):890–6.

Article  PubMed  Google Scholar 

Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–88.

Article  PubMed  PubMed Central  Google Scholar 

Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, et al. Guideline for pulmonary function testing in primary care. Chin J Gen Pract. 2019;18(6):511–8.

Google Scholar 

Asthma Group of Chinese Throacic Society. Guidelines for bronchial asthma prevent and management (2020 edition). Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(12):1023–48.

Google Scholar 

Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526.

Article  PubMed  Google Scholar 

Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2021;59(1):2102730.

Article  PubMed  Google Scholar 

Wong GWK. How should we treat patients with mild asthma? N Engl J Med. 2019;380(21):2064–6.

Article  PubMed  Google Scholar 

Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–6.

Article  CAS  PubMed  Google Scholar 

Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361(9363):1071–6.

Article  CAS  PubMed  Google Scholar 

Chow M, Pan HW, Lam JKW. Delivery technology of inhaled therapy for asthma and COPD. Adv Pharmacol. 2023;98:273–311.

Article  CAS  PubMed  Google Scholar 

Woodcock A, Beeh KM, Sagara H, et al. The environmental impact of inhaled therapy: making informed treatment choices. Eur Respir J. 2022;60(1):2102106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta S, Couillard S, Digby G, Tse SM, Green S, Penz E. Climate change and inhaler selection in patients with respiratory disease. Chest. 2024;165(3):503–6.

Article  PubMed  Google Scholar 

Woo SD, Ye YM, Lee Y, et al. Efficacy and safety of a pressurized metered-dose inhaler in older asthmatics: comparison to a dry powder inhaler in a 12-week randomized trial. Allergy Asthma Immunol Res. 2020;12(3):454–66.

Article  PubMed  PubMed Central  Google Scholar 

Kupczyk M, Majak P, Kuna P, et al. A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control—a randomized, multi-center, non-inferiority, phase IV clinical study. Respir Med. 2021;176:106274.

Article  PubMed  Google Scholar 

Morice AH, Peterson S, Beckman O, Osmanliev D. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract. 2007;61(11):1874–83.

Article  CAS  PubMed  Google Scholar 

Longest PW, Tian G, Walenga RL, Hindle M. Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways. Pharm Res. 2012;29(6):1670–88.

Article  CAS  PubMed  Google Scholar